CELZ Creative Medical Technology Holdings, Inc.
Healthcare$2.34-2.09%ClosedMarket Cap: $6.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.45
P/S
2055.92
EV/EBITDA
-0.08
DCF Value
$2.95
FCF Yield
-90.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-3986.6%
Operating Margin
-198049.6%
Net Margin
-192066.3%
ROE
-88.5%
ROA
-89.5%
ROIC
-96.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-1.5M | $-1.4M | $— | — |
| Q4 null | $3.0K | -964.8% | $-1.9M | $-1.9M | $— | — |
| FY null | $6.0K | -1992.0% | $-6.1M | $-6.0M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.3M | $-1.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.3M | $-1.2M | $— | — |
| Q1 null | $3.0K | -959.2% | $-1.7M | $-1.6M | $— | — |
| Q4 null | $3.0K | 60.0% | $-1.9M | $-1.9M | $— | — |
| FY null | $11.0K | 60.0% | $-5.7M | $-5.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.1M | $-1.0M | $— | — |
| Q2 null | $8.0K | 60.0% | $-1.6M | $-1.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.1M | $-1.0M | $— | — |
| Q4 2023 | $3.0K | -790.7% | $-1.8M | $-1.7M | $-1.21 | — |